Home OncoGenex

OncoGenex

acquired
IPO Delisting
Innovative Therapy Developer

Basic Information

OncoGenex's mission is to address the challenge of drug resistance by developing and commercializing first-class innovative therapies that have the potential to redefine treatment outcomes for patients with various types of cancer.
ONCOGENEX PHARMACEUTICALS Inc.
Washington,United States of America
51~100 people
January 01, 1991
--
--